 |
thioureidobutyronitrile |
|---|---|
| Trade Name | Kevetrin |
| Orphan Indication | Retinoblastoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-11-17 00:00:00 |
| Sponsor | Innovation Pharmaceuticals, Inc.;100 Cummings Center, Suite 151-B;Beverly, Massachusetts, 01915 |
| |
thioureidobutyronitrile |
|---|---|
| Trade Name | Kevetrin |
| Orphan Indication | Retinoblastoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-11-17 00:00:00 |
| Sponsor | Innovation Pharmaceuticals, Inc.;100 Cummings Center, Suite 151-B;Beverly, Massachusetts, 01915 |